Φορτώνει......
Investigating the impact of open label design on patient‐reported outcome results in prostate cancer randomized controlled trials
BACKGROUND: While open‐label randomized controlled trials (RCT) are common in oncology, some concerns have been expressed with regard to Patient‐Reported Outcomes (PRO)‐based claims stemming from these studies. We aimed to investigate the impact of open‐label design in the context of prostate cancer...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
John Wiley and Sons Inc.
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7571808/ https://ncbi.nlm.nih.gov/pubmed/32846465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3335 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|